Ofloxacin Antikörper

Produktnummer ABIN1089713

Produktdetails

Target: Ofloxacin

Reaktivität: Chemical

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: ELISA, Immunochromatography (IC), Immunoelectron Microscopy (IEM)

Kreuzreaktivität (Details): no significant cross-reactivity or interference was observed

Aufreinigung: Caprylic Acid Ammonium Sulfate Precipitation

Reinheit: > 95 %

Immunogen: Ofloxacin-BSA conjugate

Isotyp: IgG2b

Anwendungsinformationen

Applikationshinweise: Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: 0.03 % Proclin 300, 50 % Glycerol, 0.01 M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handhabung: Avoid freeze and thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: Shipped at 4 °C Upon delivery aliquot and store at -24 °C or -84 °C.

Antigendetails

Target: Ofloxacin

Substanzklasse: Chemical

Hintergrund: Ofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone. The original brand, Floxin, has been discontinued by the manufacturer in the United States on 18 June 2009, though generic equivalents continue to be available. Like other quinolones, ofloxacin has been associated with a significant number of serious adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible).
Synonyms: Oflocee,oflocet, oflocin, orocin, tarivid